Expertise: Women's Health 21 results
WHIS Europe
Reproductive Health Innovation Summit
Kathleen LeMaitre, M.D., FACOG
Partnership Aims to Advance Daré’s Reproductive Health Portfolio in a Timely and Capital Efficient Manner SAN DIEGO AND MORRISVILLE, N.C., November 20, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and Premier Research International, LLC, a global clinical research, product development, and consulting company, today announced that the companies extended their partnership agreement under which…
Brandi Howard, Ph.D.
Teaming Up with Sites During Trial Design
According to the Tufts Center for the Study of Drug Development (Tufts CSDD), nearly half of all clinical studies require substantial—and potentially avoidable—protocol amendments that lengthen timelines and increase costs. Tufts CSDD also notes that more than half of the substantial amendments are implemented during the study enrollment period, mainly due to difficulties in recruiting…
Premier Research Named Partner of Choice
Premier Research has been cited in a Clinical Leader article as the CRO partner of choice for Daré Bioscience. The article, “How To Build A Strong CRO Partnership And Find Drug Development Success,” explores criteria to keep in mind when selecting the ideal CRO partner and how a positive sponsor-CRO partnership led to success in…
Considerations for Clinical Studies in Contraception
Women today can choose from a wide range of effective and safe contraceptives based on their medical and lifestyle needs. Over the course of their lives, women may change contraceptive methods for a variety of reasons, such as concerns about side effects. For researchers, the objective of contraceptive development is to design products that offer…